Literature DB >> 24628665

Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib.

R Coppola1, S Zanframundo, M Verona Rinati, M Carbotti, A Graziano, G Galati, L De Florio, V Panasiti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24628665     DOI: 10.1111/jdv.12455

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  6 in total

1.  Fungal immunology in clinical practice: Magical realism or practical reality?

Authors:  Christina C Chang; Stuart M Levitz
Journal:  Med Mycol       Date:  2019-06-01       Impact factor: 4.076

2.  Reply to Bazaz and Denning.

Authors:  Georgios Chamilos; Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

3.  Mixed Skin and Soft Tissue Infection Caused by Rhodotorula glutinis and Enterococcus faecalis in a Diabetic Patient: A Case Report.

Authors:  Petros Ioannou; Despoina Chatzisymeon; Sofia Maraki; George Samonis; Diamantis P Kofteridis
Journal:  Maedica (Bucur)       Date:  2022-03

4.  Fungal Infections with Ibrutinib and Other Small-Molecule Kinase Inhibitors.

Authors:  Marissa A Zarakas; Jigar V Desai; Georgios Chamilos; Michail S Lionakis
Journal:  Curr Fungal Infect Rep       Date:  2019-07-05

5.  Draft Genome Sequence of Rhodotorula mucilaginosa, an Emergent Opportunistic Pathogen.

Authors:  Massimo Deligios; Cristina Fraumene; Marcello Abbondio; Ilaria Mannazzu; Alessandro Tanca; Maria Filippa Addis; Sergio Uzzau
Journal:  Genome Announc       Date:  2015-04-09

6.  Cutaneous candidiasis caused by Candida albicans in a young non-immunosuppressed patient: an unusual presentation.

Authors:  Enzo Palese; Maurizio Nudo; Grazia Zino; Valeria Devirgiliis; Mattia Carbotti; Eleonora Cinelli; Donatella Maria Rodio; Alessia Bressan; Carla Prezioso; Cecilia Ambrosi; Daniela Scribano; Valeria Pietropaolo; Daniela Fioriti; Vincenzo Panasiti
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.